tiprankstipranks
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market

Inhibrx Biosciences Inc (INBX) Income Statement

Compare
18 Followers

Inhibrx Biosciences Inc Income Statement

Last quarter (Q4 2024), Inhibrx Biosciences Inc's total revenue was $100.00K, a decrease of -93.88% from the same quarter last year. In Q4, Inhibrx Biosciences Inc's net income was $-47.87M. See Inhibrx Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 200.00K$ 1.80M$ 2.18M$ 7.13M$ 12.81M
Gross Profit
$ 200.00K$ 609.00K$ -668.00K$ 4.44M$ -60.69M
Operating Expenses
$ 331.65M$ 219.83M$ 131.29M$ 83.69M$ 80.25M
Depreciation and Amortization
$ 2.29M$ 1.19M$ 1.23M$ 2.69M$ 2.39M
EBITDA
$ 1.70B$ -206.69M$ -125.82M$ -76.56M$ -67.44M
Operating Income
$ -331.45M$ -219.22M$ -129.12M$ -76.56M$ -67.44M
Other Income/Expenses
$ 2.02B$ -20.50M$ -29.90M$ -5.20M$ -8.19M
Pretax Income
$ 1.69B$ -239.72M$ -145.22M$ -81.77M$ -75.63M
Net Income
$ 1.69B$ -241.36M$ -145.23M$ -81.77M$ -75.64M
Per Share Metrics
Basic EPS
$ 114.01$ -5.12$ -3.62$ -2.15$ -2.99
Diluted EPS
$ 112.62$ -5.12$ -3.62$ -2.15$ -2.99
Weighted Average Shares Outstanding
14.80M 47.13M 40.11M 38.01M 25.26M
Weighted Average Shares Outstanding (Diluted)
14.98M 47.13M 40.11M 38.01M 25.26M
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis